BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 108 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $354,000 | -22.2% | 12,185 | -3.9% | 0.04% | -32.1% |
| Q1 2021 | $455,000 | -38.3% | 12,673 | +2.7% | 0.05% | -41.1% |
| Q4 2020 | $737,000 | +2.8% | 12,339 | -7.6% | 0.09% | -30.8% |
| Q3 2020 | $717,000 | -26.4% | 13,354 | -26.6% | 0.13% | -37.5% |
| Q2 2020 | $974,000 | +312.7% | 18,205 | +137.2% | 0.21% | +271.4% |
| Q1 2020 | $236,000 | – | 7,675 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $7,040,000 | 3.41% |
| Ikarian Capital, LLC | 693,716 | $15,505,000 | 1.17% |
| EAM Global Investors LLC | 71,838 | $1,606,000 | 0.94% |
| Avidity Partners Management LP | 211,000 | $4,716,000 | 0.65% |
| MOODY ALDRICH PARTNERS LLC | 79,642 | $1,780,000 | 0.54% |
| Knoll Capital Management, LLC | 20,000 | $447,000 | 0.42% |
| EAM Investors, LLC | 55,775 | $1,247,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 299,932 | $6,703,000 | 0.22% |
| Coastal Bridge Advisors, LLC | 25,014 | $559,000 | 0.20% |
| Ikarian Capital, LLC | 103,300 | $2,309,000 | 0.17% |